Cold-climate wine grapes are produced on 8,000 ha in the North Central region of the United States. Wisconsin has experienced considerable growth, with a 26% increase in acreage since 2017. Chemical management of fungal diseases in cold-climate, interspecific hybrid grapes mirrors that of traditional Vitis vinifera cultivars despite significant differences in disease susceptibility. Most cold-climate cultivars display disease tolerance or resistance to key pathogens such as Plasmopara viticola (downy mildew), Erysiphe necator (powdery mildew), and Phyllosticta ampelicida (black rot). Current fungicide programs in Wisconsin's cold-climate grape industry underutilize genetic resistance, resulting in overreliance on at-risk fungicides and an increased threat of fungicide resistance development. In vineyard trials, the impacts of a reduced fungicide application number compared to current grower "Standard" programs was assessed for disease incidence and severity for five diseases: anthracnose, black rot, downy mildew, Phomopsis cane and leaf spot and powdery mildew. In 2022, with moderate disease pressure at both vineyard sites, there were no significant differences observed when fewer fungicides (six or five applications vs. four applications) were applied. In 2023, higher disease incidence was observed in the "Standard" spray program at one study location which received a greater number of fungicide applications. In both years, grape cultivar was a significant factor with the 'LaCrosse' displaying greater average disease severity than the 'St. Pepin' in both the "Standard" and "Reduced" Programs. These findings present a promising opportunity for cold-climate grape growers to reduce the number of fungicide applications while maintaining disease control and marketable yield.